Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents while on study
Patients may not be receiving any other investigational agents while on study
Patients must not be receiving or planning to receive any other investigational agents
Patients may not be receiving any other investigational agents while on study treatment
Patients receiving ongoing treatment with any other investigational agents are not eligible
Patients may not be receiving any other investigational agents
Patients may not be receiving or have received any other investigational agents during/or within 1 month prior
Patients receiving any other investigational agents are ineligible
Patients receiving any other investigational agents are excluded
Subjects who are receiving any other investigational agents
EXCLUSION CRITERIA FOR THIRD-LINE THERAPY: Patients receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patient is receiving any other investigational agents.
Patients who are receiving any other investigational agents
Patients receiving ongoing treatment with any other investigational agents are not eligible
Receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents.
Receiving any other investigational agents
Patients must not be receiving any other investigational agents
Receiving any other investigational agents for their lymphoma
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Receiving any other investigational agents
Patients receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational therapy
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents are excluded
Patients receiving any other investigational agents
Patients may not be receiving any other anti-neoplastic investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other therapeutic investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents, or have received investigational agents within 4 weeks of beginning treatment
Patients may not be receiving (or received prior to enrollment) any other investigational agents for metastatic disease.
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents for treatment of their kidney cancer
Patients who are receiving other investigational agents
Patients who are actively receiving any other investigational agents
Patients who are receiving any other investigational agents
Patient must not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents or other tumor-directed therapy.
Patients who are receiving any other investigational agents
Patients receiving other investigational agents.
Patients who are receiving any other investigational agents.
Patients who are receiving any other investigational agents
Patient is receiving other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents.
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents for the treatment of their breast cancer
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents are ineligible
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other anticancer or investigational agents
Patients must not be receiving any other investigational agents
Patients may not be receiving any other investigational agents within 30 days of registration
Patients must not be receiving any other investigational agents
Patients receiving other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents.
Patients who are receiving any other investigational agents
Subjects who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents.
Patients who are receiving any other investigational agents.
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents =< 28 days prior to study treatment
Patients receiving any other investigational agents within 30 days of receiving zydelig
Patients who are receiving any other investigational agents
Subjects receiving any other investigational agents
Patients receiving any other investigational agents
Patients who are receiving any other investigational agents
Subjects who are receiving any other investigational agents
Patients receiving other investigational agents
Patients receiving any other investigational agents
Patients who are receiving any investigational agents
Patients who are receiving any other investigational agents or other tumor-directed therapy
Patients receiving any other investigational agents
Subjects may not be receiving any other investigational agents
Patients who are receiving any other investigational agents within 28 days before start of study treatment
Subjects may not be receiving other investigational agents
Patients may not be receiving any other investigational agents =< 14 days from registration
Patients who are receiving any other investigational agents or have within the last 28 days
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Subjects receiving any other investigational agents
Receiving any other investigational agents within 14 days prior to enrollment
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents are ineligible
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Subjects receiving other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents (with exception of imaging agents)
Patients who are receiving any other investigational agents; however, prior enrollment on a study using investigational agents is acceptable
Patients who are receiving any other investigational agents within the preceding 4 weeks
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Subjects receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients receiving any other investigational agents
Patients receiving any investigational agents
Patients receiving any other investigational agents
Patients receiving any other investigational agents or immunotherapy
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents within the preceding 4 weeks
Subjects receiving any other investigational agents
Patients who are receiving any investigational agents
Patients who are receiving any investigational agents
Patients may not be receiving any other investigational agents
Subjects who are actively receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Subjects receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents.
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Subjects who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents nor have participated in an investigational trial within the past 4 weeks
Subjects who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational therapeutic agents
Subjects may not be receiving any other investigational agents
Patients who are receiving other investigational therapeutic agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Subjects is receiving any other investigational agents for the treatment of prostate cancer
Patients may not be receiving any other investigational agents
Subjects must not be receiving any other investigational agents
Patients receiving any other investigational agents.
Patients may not be receiving any other investigational agents
Patients receiving any other investigational agents
Patients may not be receiving any other investigational agents and/or other therapy for their cancer
Patient must not be receiving any other investigational agents
Patients may not be receiving any other investigational cancer treatment agents at the time of enrollment
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Receiving any other investigational agents =< 28 days prior to registration
Patients receiving any other investigational agents are ineligible
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Subjects who are receiving any other investigational agents
Patients receiving any other investigational agents are ineligible
The subject is receiving any other investigational agents
Patients receiving any other investigational agents
Patients may not be receiving any other investigational agents
TUMOR BIOPSY SEQUENCING: Patients who are receiving any other investigational agents; patients on other trials will be eligible as long as they are no longer receiving study treatment
TREATMENT: Patients who are receiving any other investigational agents; patients on other trials will be eligible as long as they are no longer receiving study treatment
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients must not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Subjects receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents
Patients who are receiving any other biologic, cytotoxic or investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents or patients that have received other investigational agents within 14 days of enrollment
Subjects may not be receiving any other investigational agents
Patients receiving any other investigational agents
Receiving other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents are ineligible
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any additional investigational agents or radiation therapy
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents for melanoma
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents or patients that have received other investigational agents within 14 days of enrollment
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents are not eligible
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
PHASE II: Patients may not be receiving any other investigational agents while on study
Patients must not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients receiving any other investigational agents
May not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents for cancer
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Subject who is receiving any other investigational agents;
Patients who are receiving any other investigational agents
Not receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients must not be receiving any other investigational agents
Subjects receiving any other investigational agents
Receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents or patients that have received other investigational agents within 14 days of enrollment
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Receiving any other investigational agents at the time of registration
Patients who are receiving any other investigational agents
Patients must not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Subjects receiving any other investigational agents
Patients may not be receiving any other investigational agents within 2 weeks prior to registration
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patient receiving any other investigational agents
Patients may not be receiving any other investigational cancer-directed agents
Actively receiving any investigational agents
Patients receiving any other investigational agents within 30 days prior to the first dose of trial treatment
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving other investigational agents
Patients who are receiving any other investigational agents
Subjects receiving other investigational agents are not eligible
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents or patients that have received other investigational agents within 14 days of enrollment
Patients may not be on any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Subjects may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients should not be receiving any other investigational agents
Ongoing therapy with other investigational agents. Patients may not be receiving any other investigational agents.
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents for cancer treatment
Patients may not be receiving any other investigational agents while on study treatment
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents while on study
Patient receiving any other investigational agents
Patient must not be receiving any other investigational agents
Patients who are receiving any investigational agents
Patient must not be receiving any other investigational agents
Patients who are receiving any investigational agents.
Patients may not be receiving any other investigational agents
Patients receiving any other chemotherapy or investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Subjects receiving any other investigational agents
Subjects receiving other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents.
Patients receiving any other investigational agents
Patients receiving other investigational agents
Receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients should not be receiving any other investigational agents
Patients should not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Receiving any other investigational agents
Patients may not be receiving any other investigational agents.
Patients receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents or other medications for the treatment of their malignancy
Patients receiving any other investigational agents
Patients receiving any other investigational agents are ineligible
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents or have received immunotherapy
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents or patients that have received other investigational agents within 14 days of enrollment
Patients may not be receiving any additional investigational agents or radiation therapy
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents within 28 days before start of study treatment
Patients should not be receiving any other investigational agents
Patients may not be receiving any investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patient must not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents.
Patients receiving any other investigational agents are ineligible
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients planning on receiving other investigational agents while on this study
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents or have received other investigational agents for at least 3 weeks
Patients who are receiving any other investigational agents
Patients may not be receiving any other investigational agents within 7 days of registration
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Subjects who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients who are receiving any other investigational agents
Subjects may not be receiving any investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents are ineligible
Patient must not be receiving any other investigational agents
Patient must not be actively receiving any other investigational agents
Receiving any other investigational agents =< 6 months prior to registration
Receiving any other investigational agents =< 6 months prior to Registration
Receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Receiving any other investigational agents
Receiving any other investigational, anticoagulation, and/or chemotherapy agents
Participant is receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents are ineligible
Patients may not be receiving any other investigational agents
Receiving any other investigational agents
Patient may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Patients may not be receiving any other investigational agents
Women who are receiving any other investigational agents
Receiving any investigational agents
Subjects may not be receiving any investigational agents
Patients who are receiving any other investigational agents
Patients receiving any other investigational agents within 4 weeks of starting the study
Patients may not be receiving any other investigational agents
Patients who are receiving any other investigational agents
Patients receiving
Patients who are receiving any other investigational agents
